Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
Go back to Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting| StemCells, Inc. (NASDAQ: TEM) | Delayed: 48.42 -2.42 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.84 | 52 Week High | $0.45 | |||
| Open | $49.75 | 52 Week Low | $0.37 | |||
| Day High | $51.27 | P/E | N/A | |||
| Day Low | $47.64 | EPS | $-0.31 | |||
| Volume | 3,411,355 | |||||
